CSL Annual Report 2024

Entity name (all represent body corporate entities unless otherwise specified) Australian or Foreign resident Country of Incorporation and Tax Residency1 Percentage owned (%) CSL Behring GmbH Foreign Germany 100% CSL Plasma GmbH Foreign Germany 100% CSL Behring Beteiligungs und Verwaltungs GmbH & Co KG3 Foreign Germany 100% CSL Finance GmbH Foreign Germany 100% CSL Behring Holdings GmbH Foreign Germany 100% CSL Innovation GmbH Foreign Germany 100% CSL Behring Verwaltungs GmbH Foreign Germany 100% Seqirus GmbH Foreign Germany 100% Vifor Pharma Deutschland GmbH Foreign Germany 100% CSL Behring EPE Foreign Greece 100% CSL Behring Asia Pacific Limited Foreign Hong Kong 100% CSL Plasma Kft Foreign Hungary 100% CSL Behring Kft. Foreign Hungary 100% CSL Behring Ltd Foreign Israel 100% CSL Behring SpA Foreign Italy 100% Seqirus S.r.l Foreign Italy 100% Vifor Pharma Italia S.r.l. Foreign Italy 100% CSL Behring KK Foreign Japan 100% CSL Behring Korea Ltd Foreign Korea 100% Seqirus Korea Limited Foreign Korea 100% Behring SDN. BHD. Foreign Malaysia 100% CSL Behring SA de CV Foreign Mexico 100% CSL Behring BV Foreign Netherlands 100% Seqirus Netherlands B.V. Foreign Netherlands 100% Vifor Pharma Nederland B.V. Foreign Netherlands 100% CSL Behring (NZ) Limited Foreign New Zealand 100% Seqirus (NZ) Limited Foreign New Zealand 100% CSL Behring Panama S.A. Foreign Panama 100% CSL Behring sp. z o.o. Foreign Poland 100% CSL Behring, Unipessoal, Lda Foreign Portugal 100% Vifor Pharma Portugal, S.A. Foreign Portugal 100% Vifor Pharma Romania S.R.L. Foreign Romania 100% Vifor Pharma RUS Limited Liability Company Foreign Russia 100% CSL Behring Pte. Ltd. Foreign Singapore 100% Seqirus Pte. Ltd. Foreign Singapore 100% Vifor Pharma Asia Pacific Pte. Ltd. Foreign Singapore 100% CSL Behring Slovakia sro Foreign Slovakia 100% CSL Behring, S.A. Foreign Spain 100% Seqirus Spain, S.L. Foreign Spain 100% Vifor Pharma España, S.L. Foreign Spain 100% Sanifit Therapeutics, S.A. Foreign Spain 100% CSL Behring AB Foreign Sweden 100% Vifor Pharma Nordiska AB Foreign Sweden 100% See footnotes on page 148. 147

RkJQdWJsaXNoZXIy MjE2NDg3